Li et al. reply

With respect to the mechanism that underlies this process, we proposed that phosphorylation of CtIP leads to its dissociation from BRCA1, freeing BRCA1 to participate in the activation of DNA-damage-response genes. We do, however, appreciate the potential for experimental artefact in using only soluble co-immunoprecipitation to detect protein–protein interactions, particularly when different antibodies and cell lines are used. (We used human colon cancer cell line HCT 116 and human fibroblasts GM09607A and GM00637G, whereas Wu-Baer and Baer used human bladder carcinoma cell line T24 and fibroblast GM000637H.)

Wu-Baer and Baer report reciprocal co-immunoprecipitation of BRCA1 and CtIP using two different cell lines instead of the same cells. Their observations are inconsistent with ours where the interaction status of BRCA1 and CtIP after γ-irradiation is concerned. This discrepancy should eventually be resolved by systematic investigation using an alternative and complementary method.